NuCana (NCNA) Return on Capital Employed Growth (3y) (2021 - 2025)
NuCana (NCNA) Return on Capital Employed Growth (3y) (2021 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
ROCE Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
-494.00 |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
NuCana |
29.13 Bn |
29.13 Bn |
- |
2,416.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
2,416.00 |
| Sep 30, 2025 |
-1,261.00 |
| Jun 30, 2025 |
-34,769.00 |
| Mar 31, 2025 |
-21,466.00 |
| Dec 31, 2024 |
-19,610.00 |
| Sep 30, 2024 |
-61,486.00 |
| Jun 30, 2024 |
-47,632.00 |
| Mar 31, 2024 |
-22,976.00 |
| Dec 31, 2023 |
-14,266.00 |
| Sep 30, 2023 |
-11,582.00 |
| Jun 30, 2023 |
-7,512.00 |
| Mar 31, 2023 |
-6,332.00 |
| Dec 31, 2022 |
-5,197.00 |
| Sep 30, 2022 |
-4,482.00 |
| Jun 30, 2022 |
-4,393.00 |
| Mar 31, 2022 |
-5,348.00 |
| Dec 31, 2021 |
-4,305.00 |
| Sep 30, 2021 |
-3,377.00 |
| Jun 30, 2021 |
-1,567.00 |
